BeStock  
Stocks › Biotechnology › DSGN

Design Therapeutics DSGN

US equityMarket cap rank #3474Biotechnology
$11.69 −$0.28 (-2.34%)
Pre-market · Oct 8, 8:20 am ET · After hours $11.69 0.00%
Open$11.82
Prev close$11.97
Day range$11.58 – $12.06
Volume344.5K
Market cap$731.58M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.2%-1.01 pts vs. prior quarter
Institutions holding170-1 vs. prior quarter
Insider trades (recent)37 buys / 6 sellsNet buying
Short interest8.73% of floatDays to cover 7.3 · as of 15 Sep 2026
Short-sale volume share28.2%5-day average of daily volume

Short-sale volume as % of daily volume

19%25%30%36%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$537.1K (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$2.0MSuper−$1.4MBig−$1.2MMid−$8.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.6% of shares outstanding.

Largest holders

  • Aseem Ansari12.25%
  • SR One Capital Management, LP10.43%
  • Sirenia Capital Management LP8.71%
  • Light Irrevocable Trusts6.13%
  • Star Irrevocable Trust6.13%
  • Quan Management LLC5.41%
  • Logos Global Management, L.P.4.79%
  • Baker Bros. Advisors LP4.28%

By investor type

  • Mutual Fund32.80%
  • Hedge Fund30.01%
  • VC/PE Fund18.12%
  • Individual/Insider14.08%
  • Private Company12.47%
  • Public Company2.25%
  • Government Pension Fund0.29%
  • Insurance Company0.16%

Reported short interest has fallen from 9.15% to 8.73% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Sirenia Capital Management LP Mutual Fund 2026/Q3 +5,453,736 8.7%
Frazier Life Sciences Management, LP VC/PE Fund 2026/Q3 +1,809,854 2.9%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +1,149,269 3.2%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +1,050,000 4.8%
Caption Management, LLC Hedge Fund 2026/Q3 +1,031,390 1.8%
Driehaus Capital Management LLC Mutual Fund 2026/Q3 +916,128 4.3%
Sofinnova Investments, Inc. VC/PE Fund 2026/Q3 +865,135 1.4%
BlackRock Mutual Fund 2026/Q3 +526,260 4.3%
Artal Group S.A. VC/PE Fund 2026/Q3 +523,212 0.8%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +402,896 0.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +333,053 0.7%
Jacobs Levy Equity Management Inc Mutual Fund 2026/Q3 +276,212 0.9%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +265,899 1.5%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +262,903 1.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +255,716 2.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Jun 2026 John Schmid Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Justin Gover Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 David Shapiro Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Rodney Lappe Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Simeon George Lead Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Heather Berger Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
30 Mar 2026 David Shapiro Independent Director Other Derivative Acquisition +67,500 $10.64 7,500
1 Jan 2026 Pratik Shah Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson Other Derivative Acquisition +750,000 $9.10 750,000
1 Jan 2026 Justin Gover Director Other Derivative Acquisition +45,000 $9.10 45,000
1 Jan 2026 Chris Storgard Chief Medical Officer Other Derivative Acquisition +250,000 $9.10 250,000
1 Jan 2026 Sean Jeffries Chief Operating Officer Other Derivative Acquisition +375,000 $9.10 375,000
1 Jan 2026 Julie Burgess Chief Accounting Officer Other Derivative Acquisition +150,000 $9.10 150,000
8 Dec 2025 Pratik Shah Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson Other Derivative Acquisition +1,050,000 $2.48 525,000
17 Nov 2025 Logos Global Management, L.P. Intent to Sell (Form 144) -120,000 $7.43 –
13 Nov 2025 Logos Global Management, L.P. Intent to Sell (Form 144) -620,000 $7.06 –
6 Nov 2025 Logos Global Management, L.P. Intent to Sell (Form 144) -415,000 $6.87 –
8 Sep 2025 Justin Gover Director Other Derivative Acquisition +45,833 $6.64 15,833
12 Aug 2025 Logos Global Management, L.P. Open Market Disposition -562,627 $5.25 3,655,000
9 Jun 2025 John Schmid Independent Director Other Derivative Acquisition +19,000 $4.01 19,000
9 Jun 2025 Rodney Lappe Independent Director Other Derivative Acquisition +19,000 $4.01 19,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 5,461,508 8.7% 7.3
31 Aug 2026 5,542,463 8.9% 9.0
14 Aug 2026 5,925,557 9.5% 15.2
31 Jul 2026 5,952,223 9.5% 12.0
15 Jul 2026 5,669,571 9.1% 6.4
30 Jun 2026 5,715,760 9.2% 5.2

Discussion

No comments yet — be the first to weigh in on DSGN.

Leave a comment

Scroll to Top